Simultaneous targeting of telomeres and telomerase as a cancer therapeutic approach

Cancer Research

Volumn 63, Issue 3, 2003, Pages 579-585

  Mo, Yiqun ^a   Gan, Yuebo ^a   Song, SaeHeum ^a   Johnston, Jeffrey ^a   Xiao, Xiaodong ^a   Wientjes, M Guillaume ^a,b   Au, Jessie L S ^a,b,c  

^a OHIO STATE UNIVERSITY   (United States)

^b OHIO STATE UNIVERSITY   (United States)

^c NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CEFOTAXIME; CINCHONINE; PACLITAXEL; SULFORHODAMINE B; TELOMERASE; ZIDOVUDINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CANCER THERAPY; CELL DIVISION; CELL GROWTH; CHROMOSOME; CONTROLLED STUDY; CYTOTOXICITY; DRUG POTENTIATION; DRUG SENSITIVITY; ENZYME INHIBITION; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; SOMATIC CELL; TELOMERE; XENOGRAFT;

ANIMALS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; COMBINED MODALITY THERAPY; DRUG SYNERGISM; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; MALE; MICE; MICE, INBRED BALB C; MICE, NUDE; OSTEOSARCOMA; PACLITAXEL; PHARYNGEAL NEOPLASMS; RNA, ANTISENSE; TELOMERASE; TELOMERE; TUMOR CELLS, CULTURED; XENOGRAFT MODEL ANTITUMOR ASSAYS; ZIDOVUDINE;

EID: 0037308546     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Zakian, V. A. Telomeres: beginning to understand the end. Science (Wash. DC), 270: 1601-1607, 1995.
2. Urquidi, V., Tarin, D., and Goodison, S. Role of telomerase in cell senescence and oncogenesis. Ann. Rev. Med., 51: 65-79, 2000.
3. Fu, W., Begley, J. G., Killen, M. W., and Mattson, M. P. Anti-apoptosis role of telomerase in pheochromocytoma cells. J. Biol. Chem., 274: 7264-7271, 1999.
4. Nugent, C. I., Bosco, G., Ross, L. O., Evans, S. K., Salinger, A. P., Moore, J. K., Haber, J. E., and Lundblad, V. Telomere maintenance is dependent on activities required for end repair of double-strand breaks. Curr. Biol. 11, 657-660, 1998.
5. Ishikawa, T., Kamiyama, M., Hisatomi, H., Ichikawa, Y., Momiyama, N., Hamaguchi, Y., Hasegawa, S., Narita, T., and Shimada, H. Telomerase enzyme activity and RNA expression in adriamycin-resistant human breast carcinoma MCF-7 cells. Cancer Lett., 141: 187-194, 1999.
6. Kim, N. W., Piatyszek, M. A., Prowse, K. R., Harley, C. B., West, M. D., Ho, P. L., Coviello, G. M., Wright, W. E., Weinrich, S. L., and Shay, J. W. Specific association of human telomerase activity with immortal cells and cancer. Science (Wash. DC), 266: 2011-2015, 1994.
7. Feng, J., Funk, W. D., Wang, S. S., Weinrich, S. L., Avilion, A. A., Chiu, C. P., Adams, R. R., Chang, E., Allsopp, R. C., Yu, J., Le, S., West, M. D., Harley, C. B., Andrews, W. H., Greider, C. W., and Villeponteau, B. The RNA component of human telomerase. Science (Wash. DC), 269: 1236-1241, 1995.
8. Bryan, T. M., Englezou, A., Dalla-Pozza, L., Dunham, M. A., and Reddel, R. R. Evidence for an alternative mechanism for maintaining telomere length in human tumors and tumor-derived cell lines. Nat. Med., 3: 1271-1274, 1997.
9. Multani, A. S., Li, C., Ozen, M., Iman, A. S., Wallace, S., and Pathak, S. Cell-killing by paclitaxel in a metastatic murine melanoma cell line is mediated by extensive telomere erosion with no decrease in telomerase activity. Oncol. Rep., 6: 39-44. 1999.
10. Strahl, C., and Blackburn, E. H. Effects of reverse transcriptase inhibitors on telomere length and telomerase activity in two immortalized human cell lines. Mol. Cell. Biol., 16: 53-65, 1996.
11. Melana, S. M., Holland, J. F., and Pogo, B. G. T. Inhibition of cell growth and telomerase activity of breast cancer cells in vitro by 3′-azido-3′-deoxythymidine. Clin. Cancer Res., 4: 693-696, 1998.
12. Mazumder, A., Cooney, D., Agbaria, R., Gupta, M., and Pommier, Y. Inhibition of human immunodeficiency virus type 1 integrase by 3′-azido- 3′-deoxythymidylate. Proc. Natl. Acad. Sci. USA, 91: 5771-5775, 1994.
13. Lewis, W., and Dalakas, M. Mitochondrial toxicity of antiviral drugs. Nat. Med., 1: 417-422, 1995.
14. Jacobsson, B., Britton, S., He, Q., Karlsson, A., and Ericksson, S. Decreased thymidine kinase levels in peripheral blood cells from HIV-seropositive individuals: implications for zidovudine metabolism. AIDS Res. Hum. Retroviruses, 11: 805-811, 1995.
15. Olivero, O. A., and Poirier, M. C. Preferential incorporation of 3′-azido-2′,3′-dideoxythymidine into telomeric DNA and Z-DNA-containing regions of Chinese hamster ovary cells. Mol. Carcinog., 8: 81-88, 1993.
16. Gan, Y., Lu, J., Johnson, A., Wientjes, M. G., Schuller, D. E., and Au, J. L. S. A quantitative assay of telomerase activity. Pharm. Res., 4: 488-493, 2001.
17. Naasani, I., Seimiya, H., and Tsuruo, T. Telomerase inhibition, telomere shortening, and senescence of cancer cells by tea catechins. Biochem. Biophys. Res. Commun., 249: 391-396, 1998.
18. Gan, Y., Engelke, K. J., Brown, C. A., and Au, J. L. S. Telomere amount and length assay. Pharm. Res., 18: 1655-1659, 2001.
19. Rufer, N., Dragowska, W., Thornbury, G., Roosnek, E., and Lansdorp, P. M. Telomere length dynamics in human lymphocyte subpopulations measured by flow cytometry. Nat. Biotechnol., 16: 743-747, 1998.
20. Au, J. L. S., Li, D., Gan, Y. B., Gao, X., Johnson, A. L., Johnston, J., Millenbaugh, N. J., Jang, S. H., Huh, H. J., Chen, C. T., and Wientjes, M. G. Pharmacodynamics of immediate and delayed effects of paclitaxel: role of slow apoptosis and intracellular drug retention. Cancer Res., 58: 2141-2148, 1998.
21. Riccardi, A., Meco, D., Ferlini, C., Servidei, T., Careli, G., Segni, G., Manzotti, C., and Riccardi, R. In vitro and in vivo antitumor activity of the novel trinuclear platinum complex BBR 3464 in neuroblastoma. Cancer Chemother. Pharmacol., 47: 498-504, 2001.
22. Song, S. H., Wientjes, M. G., Gan, Y., and Au, J. L. S. Fibroblast growth factors: an epigenetic mechanism of broad spectrum resistance to anticancer drugs. Proc. Natl. Acad. Sci. USA, 97: 8658-8663, 2000.
23. Chang, B. D., Xuan, Y., Broude, E. V., Zhu, H., Schott, B., Fang, J., and Roninson, I. B. Role of p53 and p21waf1/cip1 in senescence-like terminal proliferation arrest induced in human tumor cells by chemotherapeutic drugs. Oncogene. 34: 4808-4818, 1999.
24. Arbuck, S. G., and Blaylock, B. A. Taxol: clinical results and current issues in development. In: S. Matthew (ed.), Taxol: Science and Applications. pp. 379-417. Boca Raton, FL: CRC Press, 1995.
25. Gan, Y., Wientjes, M. G., Schuller, D. E., and Au, J. L. S. Pharmacodynamics of taxol in human head and neck tumors. Cancer Res., 56: 2086-2093, 1996.
26. Stone, A. A., and Chambers, T. C. Microtubule inhibitors elicit differential effects on MAP kinase (JNK, ERK, and p38) signaling pathways in human KB-3 carcinoma cells. Exp. Cell Res., 254: 110-119, 2000.
27. Au, J. L-S., Kumar, R. R., Li, D., and Wientjes, M. G. Kinetics of hallmark biochemical changes in paclitaxel-induced apoptosis. AAPS PharmSci., 1: 1-7, 1999.
28. Moos., P. J., and Fitzpatrick, F. A. Taxanes propagate apoptosis via two cell populations with distinctive cytological and molecular traits. Cell Growth Differ., 9: 687-697, 1998.
29. Gangemi, R. M. R., Santamara, B., Bargellesi, A., Cosulich, E., and Fabbi, M. Late apoptotic effects of taxanes on K562 erythroleukemia cells: apoptosis is delayed upstream of caspase-3 activation. Int. J. Cancer, 85: 527-533, 2000.
30. Ren, J. G., Xia, H. L., Just, T., and Dai, Y. R. Expression of telomerase inhibits hydroxyl radicai-induced apoptosis in normal telomerase negative human lung fibroblasts. FEBS Lett., 488: 123-132, 2001.
31. Hahn, W. C., Stewart, S. A., Brooks, M. W., York, S. G., Eaton, E., Kurachi, A., Beijersbergen, R. L., Knoll, J. H. M., Meyerson, M., and Weinberg, R. A. Inhibition of telomerase limits the growth of human cancer cells. Nat. Med., 5: 1164-1170, 1999.
32. Kondo, Y., Kondo, S., Tanaka, Y., Haqqi, T., Bama, B. P., and Cowell, J. K. Inhibition of telomerase increases the susceptibility of human malignant glioblastoma cells to cisplatin-induced apoptosis. Oncogene, 16: 2243-2248, 1998.
33. Kondo, S., Tanaka, Y., Kondo, Y., Hitomi, M., Barnett, G. H., Ishizaka, Y., Liu, J., Haqqi, T., Nishiyama, A., Villeponteau, B., Cowell, J. K., and Barna, B. Antisense telomerase treatment: induction of two distinct pathways, apoptosis and differentiation. FASEB J., 12: 801-811, 1998.
34. Herbert, B. S., Pitts, A. E., Baker, S. I., Hamilton, S. E., Wright, W. E., Shay, J. W., and Corey, D. R. Inhibition of human telomerase in immortal human cells leads to progressive telomere shortening and cell death. Proc. Natl. Acad. Sci. USA, 96: 14276-14281, 1999.
35. Holt, S. E., Glinsky, V. V., Ivanova, A. B., and Glinsky, G. V. Resistance to apoptosis in human cells conferred by telomerase function and telomere stability. Mol. Carcinog., 25: 241-248, 1999.
36. de Lange. T. Activation of telomerase in a human tumor. Proc. Natl. Acad. Sci. USA, 91: 2882-2885, 1994.
37. Wagner, C. R., Ballato, G., Akanni, A. O., McIntee, E. J., Larson, R. S., Chang, S., and Abul-Hajj, Y. J. Potent growth inhibitory activity of zidovudine on cultured human breast cancer cells and rat mammary tumors. Cancer Res., 57: 2341-2345, 1997.